A Randomized, Double Blind, Phase II Trial of Cisplatin Plus Etoposide with/without Concurrent ZD6474 in Patients with Previously Untreated Extensive Stage Small Cell Lung Cancer

Patients with SCLC who have never been treated will be randomized to receive Cisplatin and Etoposide with or without ZD6474 (oral pill).